Product
Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1
Aliases
Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum
2 clinical trials
1 indication
Indication
Triple-negative Breast CancerClinical trial
a Pilot Study to Explore the Efficacy of Inosine Reversing Chemo Resistance in Triple Negative Breast CancerStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
a Pilot Study to Explore the Efficacy and Safety of Dasatinib Combined With Quercetin to Reverse Chemotherapy Resistance in Triple Negative Breast Cancer.Status: Not yet recruiting, Estimated PCD: 2024-12-31